VRS_031 - Characteristics, comorbidities, and prescription medication treatment in Chinese patients with osteoporosis: A cross-sectional study
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: VRS_031
- By: YAO, Dongning
- Co-author(s): Ms Shuo Zhang
Dr Nan Peng
Ms Mengyao Xue
Prof Dongning Yao - Abstract:
Introduction: Osteoporosis is a condition marked by low bone mass and compromised bone quality, resulting in increasing fracture risk. The China Osteoporosis Epidemiological Survey reported a prevalence of 19.2% among individuals aged ≥50 years (32.1% in women, 6.0% in men). China’s diverse pharmacological options, including vitamin D analogs..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025